SCHEMBL24313971

SCHEMBL24313971

O=C(NS(=O)(=O)c1ccccc1-c1ccccc1)c1cc2ccc(C(F)F)cc2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.41
BCAT1 P54687 1/20 0.40
MMP2 P08253 4/20 0.39
CASP1 P29466 2/20 0.39
PTGER4 P35408 1/20 0.39
FBP1 P09467 1/20 0.38
MMP13 P45452 3/20 0.38
ADAMTS4 O75173 1/20 0.38
MMP7 P09237 1/20 0.38
MMP12 P39900 1/20 0.38
MMP14 P50281 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
NPC1 O15118 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31723097 1.00 ALDH1A1 (0.41) ALDH1A1LMNATHRBBCAT1MMP2
SCHEMBL31723078 0.92 ALDH1A1 (0.43) ALDH1A1LMNATHRBBCAT1MMP2
SCHEMBL31723093 0.90 TAS1R3 (0.42) ALDH1A1LMNATHRBMMP2PTGER4
SCHEMBL24313815 0.90 TAS1R3 (0.42) ALDH1A1LMNATHRBMMP2PTGER4
SCHEMBL22588427 0.85 BCAT1 (0.43) ALDH1A1LMNABCAT1MMP2CASP1
SCHEMBL30538408 0.84 BCAT1 (0.55) ALDH1A1LMNATHRBBCAT1MMP2
SCHEMBL24313791 0.84 KDM4E (0.51) ALDH1A1LMNABCAT1PTGER4FBP1
SCHEMBL24313562 0.84 NPC1 (0.46) ALDH1A1BCAT1MMP2CASP1PTGER4
SCHEMBL22588433 0.84 BCAT1 (0.48) ALDH1A1BCAT1MMP2CASP1PTGER4
SCHEMBL31723074 0.84 KDM4E (0.51) ALDH1A1LMNABCAT1PTGER4FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed